AAKAAR
AAKAAR financials
- Market cap
- ₹89 Cr
- Sector
- Fast Moving Consumer Goods
- Calls analysed
- 2
AAKAAR Q4 FY26
What went well
- H2 FY26 revenue of ₹41.63 crores, up 23% year-on-year and 64% over H1, demonstrating a decisive rebound after H1.
- Record half-year levels for H2 EBITDA at ₹10.95 crores and PAT at ₹4 crores, with EBITDA margin at 26.3% and PAT margin at 17.77%.
- Full year FY26 revenue grew to ₹67 crores (up 8.76% YoY), with EBITDA at ₹10.97 crores (up 11.82% YoY) and PAT at ₹6.6 crores (up 10% YoY), reflecting compounding profitability.
What to watch
- H1 FY26 reported a PAT loss of ₹0.78 crores (78 lakhs negative) due to upfront investments in conferences, workshops, and internal cycle meetings.
- Siax business experienced a degrowth of over ₹1.5 crores due to delays in obtaining licenses for the new Letybo brand at the DCGI level.
Guidance record · Q4 FY26
updates from the last two tracked quarters 12 tracked 1 delivered 1 missed 10 open- EBITDA Growth delivered said Q2 FY26 Promised: better than last year Q4 FY26: FY26 EBITDA was 10.97 crores, up 11.82% YoY, successfully achieving the target.
- SKU Count went quiet said Q2 FY26 Promised: 163-164 this year Q4 FY26: No specific update on the final SKU count for FY26 was provided in the Q4 FY26 call.
- Receivable / Debtor Days revised down said Q2 FY26 Promised: below 100 by year-end Q4 FY26: Debtor days reduced to 167 by March 2026. The target was revised to a less ambitious 110 days, with management noting the difficulty of reaching sub-100 levels.
All 12 tracked — see the targets, revisions and supporting evidence.
Open the guidance ledgerQuarterly results
| Line item | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue | 34 | 25 | 42 |
| EBITDA | 8 | -0 | 10 |
| Net profit | 6 | -1 | 7 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −29.2% 1Y
1Y: ₹89 on 15 Sept 2025 → ₹63. High ₹95.75 (22 Sept 2025), low ₹48 (13 Feb 2026).
How the price took the results
close before → close after
- Q4 FY26
- 0.0%
- 15 May
- Q2 FY26
- −4.6%
- 10 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Balance sheet
| Year ending | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹10 Cr | ₹14 Cr |
| Reserves | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹12 Cr | ₹13 Cr | ₹40 Cr |
| Borrowings | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹15 Cr | ₹23 Cr | ₹19 Cr |
| Other liabilities | ₹3 Cr | ₹6 Cr | ₹8 Cr | ₹6 Cr | ₹8 Cr | ₹6 Cr |
| Total liabilities | ₹14 Cr | ₹18 Cr | ₹23 Cr | ₹34 Cr | ₹54 Cr | ₹79 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹14 Cr | ₹18 Cr | ₹23 Cr | ₹34 Cr | ₹54 Cr | ₹79 Cr |
| Total assets | ₹14 Cr | ₹18 Cr | ₹23 Cr | ₹34 Cr | ₹54 Cr | ₹79 Cr |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
Since Jun 2025, the public added +2.99 pp while FIIs trimmed −1.87 pp. The shareholder count shrank 40% to 550.
- Promoters
- 67.0%
- DIIs
- 11.2%
- Public
- 21.8%
Since Jun 2025
- Public +2.99 pp
- FIIs −1.87 pp
- DIIs −1.16 pp
How it drifted, 3 quarters
Over this window the public went from 18.8% to 21.8% — +3.0 pp.
Ownership split by quarter, oldest first. Jun '25: Promoters 67.0%, FIIs 1.9%, DIIs 12.3%, Public 18.8%.Sep '25: Promoters 67.0%, FIIs 0.5%, DIIs 10.7%, Public 21.8%.Mar '26: Promoters 67.0%, DIIs 11.2%, Public 21.8%.
Who bought this quarter
since Sep 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Chaitanya Gadia newly disclosed 1.20% held
- Aarth AIF Growth Fund AIF +0.32 pp 3.61% held
- Dilip Meswani Huf newly disclosed 0.00% held
- Aesthetic Solutions-Huf newly disclosed 0.00% held
- Coherent Medical Systems newly disclosed 0.00% held
- Revigen Medicare Private Limited newly disclosed 0.00% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of AAKAAR above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| Dilip Ramesh Meswani | 48.20% | unchanged |
| Bindi Dilip Meswani | 12.84% | unchanged |
| India Equity Fund 1 AIF | 4.97% | unchanged |
| Key Managerial Personnel | 4.10% | unchanged |
| Rahul B Sawakhande | 4.10% | unchanged |
| Aarth AIF Growth Fund AIF | 3.61% | +0.32 pp |
| Abhash Meswani | 2.50% | unchanged |
| Sharda Rameshchandra Meswani | 2.02% | unchanged |
| Milouni Dilip Meswani | 1.49% | unchanged |
| Chaitanya Gadia | 1.20% | newly disclosed |
| Grobiz Sme Opportunity Fund AIF | 1.10% | unchanged |
| Jasuben Himatlal Dani | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
All earnings calls (2)
Read the Q4 FY26 call →Learn to analyse AAKAAR
Guides on how to read this kind of business and the numbers that matter.